NYSCF Scientific Discovery Biobank
NCT06203106 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2025-03-03
Summary
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and store the samples for future use.
Through this research, researchers hope to identify future treatments or even cures for the major diseases of our time.
Conditions
- ALS
- Amyotrophic Lateral Sclerosis
- Alzheimer Disease
- Alzheimer Disease, Early Onset
- Alzheimer Disease, Late Onset
- Batten Disease
- Corticobasal Degeneration
- Dementia
- Frontotemporal Dementia
- Huntington Disease
- Lewy Body Disease
- Multiple Sclerosis
- Multiple System Atrophy
- Parkinson Disease
- Parkinson's Disease and Parkinsonism
- Progressive Supranuclear Palsy
- INAD
- Diabetes
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1
- Macular Degeneration
- Ovarian Cancer
- Cervical Cancer
- Uterine Cancer
- Vaginal Cancer
- Vulvar Cancer
- PTSD
- Post Traumatic Stress Disorder
Interventions
- OTHER
-
Biological Sample Collection
Skin biopsy (2-3mm) and/or blood (up to 50 mL); saliva; excess/ leftover biospecimens that were (or will be) collected for other purposes (e.g., medical procedure).
Sponsors & Collaborators
-
New York Stem Cell Foundation Research Institute
lead OTHER
Principal Investigators
-
Laura Andres-Martin, PhD · New York Stem Cell Foundation Research Institute
Eligibility
- Min Age
- 30 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-10
- Primary Completion
- 2045-11-10
- Completion
- 2045-11-10
Countries
- United States
Study Locations
More Related Trials
-
Allogeneic Mesenchymal Human Stem Cells Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects
NCT02886884 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MSC Therapy in Liver Transplantation
NCT02260375 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Trial on Diabetic Foot Using Peripheral Blood Derived Stem Cells for Treating Critical Limb Ischemia
NCT00922389 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease
NCT02032446 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Stem Cell Study for Long COVID-19 Neurological Symptoms
NCT06156241 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Stem Cell Therapy for Patients With Vascular Occlusive Diseases Such as Diabetic Foot
NCT02304588 ·Status: UNKNOWN ·Phase: PHASE1
-
MSC and Kidney Transplant Tolerance (Phase A)
NCT02565459 ·Status: UNKNOWN ·Phase: PHASE1
-
Adipose Derived Stem Cells in Facial Fat Grafting
NCT02526576 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery
NCT02648386 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products
NCT01071577 ·Status: TERMINATED
-
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)
NCT04776239 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Ophthalmology Treatment Study
NCT01920867 ·Status: UNKNOWN ·Phase: NA
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
NCT05667649 ·Status: RECRUITING ·Phase: PHASE1
-
Blood Collection From Healthy Volunteers and Patients for the Production of Clinical Grade Induced Pluripotent Stem Cell (iPSC) Products
NCT02056613 ·Status: WITHDRAWN
-
Clinical Trial With MSC for Graft Versus Host Disease Treatment
NCT02687646 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cardiomyopathy Tissue Bank in a Cancer Population
NCT00500734 ·Status: UNKNOWN
-
Stem Cell Collection for Adult Volunteers
NCT00033774 ·Status: TERMINATED
-
NEPHSTROM for Diabetic Kidney Disease
NCT02585622 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Safety of Adipose-Derived Stem Cell Stromal Vascular Fraction
NCT02590042 ·Status: UNKNOWN ·Phase: PHASE1
-
Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders
NCT05794425 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Phase I/II Safety and Tolerability Dose Escalation Study of Autologous Stem Cells to Patients With Liver Insufficiency
NCT00655707 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Study for Patients With Heart Disease
NCT00081913 ·Status: COMPLETED ·Phase: PHASE1
-
Stem Cell Injection for Peripheral Vascular Disease
NCT00278603 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Bone Marrow Transplant in Chronic Insulin Dependent Diabetic Patients
NCT03562208 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Manufacturing of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells for Treatment of Severe Systemic Sclerosis
NCT05947682 ·Status: UNKNOWN ·Phase: NA